Regeneron Pharma (REGN) PT Raised to $742 at Baird
Tweet Send to a Friend
(Updated - January 30, 2026 1:55 PM EST)
Baird analyst Brian Skorney raised the price target on Regeneron Pharma ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Baird analyst Brian Skorney raised the price target on Regeneron Pharma ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE


